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 ABSTRACT 
Purpose: To characterize and optimize 19F MRI for different perfluorocarbons (PFCs) at 
3 T and to quantify the loss of acquisition efficiency as a function of different 
temperature and cellular conditions.     
Methods: T1 and T2 relaxation times of the commonly used PFCs perfluoropolyether 
(PFPE), perfluoro-15-crown-5-ether (PFCE), and perfluorooctyl bromide (PFOB) were 
measured in phantoms and in several different conditions (cell types, presence of 
fixation agent, and temperatures). These relaxation times were used to optimize pulse 
sequences through numerical simulations. The acquisition efficiency in each cellular 
condition was then determined as the ratio of the signal after optimization with the 
reference relaxation times and after optimization with its proper relaxation times. Finally, 
PFC detection limits were determined.  
Results: The loss of acquisition efficiency due to parameter settings optimized for the 
wrong temperature and cellular condition was limited to 13%. The detection limits of all 
PFCs were lower at 24°C than at 37°C, and varied from 11.8±3.0 mM for PFCE at 24°C 
to 379.9±51.8 mM for PFOB at 37°C. 
Conclusion: Optimizing 19F pulse sequences with a known phantom only leads to 
moderate loss in acquisition efficiency in cellular conditions that might be encountered 
in in vivo and in vitro experiments.  
Key Words: fluorine MRI, turbo spin echo, balanced steady-state free precession, 
perfluorocarbon, pulse sequence optimization, detection limit 
 
 
 
 
 
 INTRODUCTION 
Fluorine-19 (19F) MRI of perfluorocarbon (PFC) emulsions has increasingly been used 
in studies of inflammation due to its high specificity and chemical inertness (1,2). The 
lack of natural 19F MR signal in the human body makes fluorine atoms a perfect 
candidate for an unambiguous biomarker without any natural background signal. For 
this reason, 19F MRI offers the opportunity to locate and identify an injected substance 
with a high contrast-to-noise ratio (CNR) and specificity of the signal. Moreover, 
assuming constant radio frequency field strength B1, the received MR signal is directly 
proportional to the amount of 19F nuclei per voxel and the signal can be referenced to a 
known 19F concentration, which gives 19F MRI the potential to be directly quantitative 
(3). For these reasons, 19F MRI of PFC emulsions has been used to image inflammation 
in vivo in animal models of cardiac and cerebral ischemia, myocarditis (3), 
atherosclerosis (4), pneumonia (5), and arthritis (6). The PFC nanoparticles are taken 
up by phagocytic cells and then accumulate at inflammatory loci in very high 
concentrations (7). Fluorescence and transmission electron microscopy have been used 
to confirm the intracellular colocalization of the PFC nanoparticles with phagocytic cells 
(8). 
One of the primary translational goals of this technique includes inflammation imaging in 
patients in a clinical setting. The main technical challenge of 19F MRI at lower magnetic 
field strengths is its low signal-to-noise ratio (SNR) per unit time. To overcome this 
challenge, the fluorinated biomarker needs to have a high 19F molarity and needs to 
accumulate at high concentrations in the tissue under investigation. This strategy can 
be implemented through the use of specifically designed perfluorocarbons (PFCs). 
PFCs are derived from hydrocarbons by replacing all the hydrogen atoms with fluorine 
atoms. These 19F based contrast agents are inert and non-toxic, and some of them 
have been used in American Food and Drug Administration (FDA) trials as blood 
volume expanders (9). 19F MRI of PFCs additionally needs pulse sequences that result 
in high SNR per unit time, and this can be accomplished by means of adequate pulse 
sequence choice and parameter optimization. Such optimization mainly depends on the 
19F relaxation times, which in the case of PFCs have been demonstrated to depend on 
 temperature (10), magnetic field strength (10), and the tissue oxygenation level (11,12). 
It therefore follows that the optimal 19F pulse sequence parameters will also change with 
the cellular environment of the used PFC. However, the T1 and T2 relaxation times 
cannot be quantified in each tissue and cell type before each scan, and approximate 
values from a well characterized phantom have to be assumed. Since the relaxation 
times of PFCs are significantly influenced by their direct cellular environment, the 
degree of signal loss caused by incorrectly optimizing pulse sequences by assuming 
relaxation times of a reference phantom instead of the cellular conditions of interest 
should be established. This signal loss in an environment due to “inaccurate” 
optimization is named the acquisition efficiency η in this study. It is defined as the ratio 
of the simulated signal after optimization with reference phantom relaxation times and 
the simulated signal after optimization with the actual relaxation times in that 
environment.  
In particular, in-vitro bone-marrow-derived macrophages (13,14), ex-vivo livers (7,15), 
and fixed ex-vivo spleen cells suspensions (15,16) were studied, since these three 
groups represent the most common environments in which PFCs are imaged (without 
the confounding factors and variability that in-vivo studies would add). Macrophages are 
crucially important for 19F MRI of inflammation, since they phagocytize the majority of 
the injected PFC nanoparticles at inflammation sites (16). Similarly, right after injection, 
a large part of the circulating PFC particles are phagocytized by the reticuloendothelial 
system, in particular liver and spleen (7). This will often result in the highest overall 
signal intensity in the body in these two organs, which renders them a common test and 
optimization target for 19F MRI. Finally, since ex-vivo NMR analysis (16) can be 
performed on fixed PFC-loaded cell samples in order to analyze the PFC biodistribution, 
formaldehyde-fixed cell suspensions from spleen were analyzed as well. 
Several PFCs with different characteristics have been used for inflammation imaging. In 
this study, the commonly used PFCs perfluoropolyether (PFPE), perfluoro-15-crown-5-
ether (PFCE), and perfluorooctyl bromide (PFOB) have been investigated. PFPE is a 
relatively new MRI biomarker, has a linear structure with nearly magnetically equivalent 
19F atoms that results in a single large peak at clinical field strength, and has been used 
 in several preclinical inflammation studies (17,18) as well as in an FDA Phase I clinical 
trial for stage-4 colorectal cancer treatment (19). The second PFC of interest, PFCE, is 
characterized by 20 magnetically equivalent 19F atoms and therefore has a single 
spectroscopic peak, but it has both long relaxation times and biological retention times, 
which might complicate its translation to the clinical setting (15). The third PFC, PFOB, 
has already been used as oxygen carrier (20) and blood volume expander in clinical 
trials (9), but it exhibits a complex spectrum with several resonances (15), which makes 
MRI more challenging.  
In order to characterize and compare these three different PFCs, it is necessary to 
determine their relaxation times and their detection limits as a function of acquisition 
time, voxel size, and pulse sequence. This detection limit should be determined after 
the sensitivity of the pulse sequence is optimized by adapting the pulse sequence 
parameters as a function of the relaxation times. In this study we investigated two of the 
most commonly used 19F MRI pulse sequences, i.e. the turbo spin echo (TSE) and the 
balanced steady state free precession (bSSFP). 
The goals of this study were therefore: (I) to determine the 19F relaxation times at 3 T for 
several commonly used PFCs at different temperature and cellular conditions; (II) to 
characterize the impact of changes in relaxation times of a given PFC to demonstrate 
the effect of different temperature and cellular conditions on the optimization of the TSE 
pulse sequence; (III) to evaluate and compare the detection limit for the three PFCs 
using both the TSE and bSSFP pulse sequences.  
METHODS 
Phantom Construction  
Three PFC emulsions were evaluated in this study. PFPE was purchased from 
Celsense Inc (Pittsburgh, PA) at a 19F concentration of 4.20 M (and thus a PFC 
concentration of 0.09 M), while PFCE and PFOB emulsions were prepared as 
previously described (15) at 19F concentration of 3.79 M (PFC concentration of 0.19 M) 
and 23.85 M (PFC concentration of 1.40 M), respectively. For each PFC emulsion, a 
 dilution series phantom was constructed in order to establish the detection limits. Five 1 
mL syringes with 2% w/v agar gel and PFC at different concentrations were placed 
inside a 50 mL tube with 2% w/v agar gel and no PFC. For the first syringe, the original 
emulsion was diluted by a factor of 4 to accommodate the agar gel that mimics the 
solidity of a tissue, after which it was diluted twice each time for the subsequent 
syringes to cover a broad range of concentrations. The last syringe in all the phantoms 
served as a control and did not contain any PFC.  
Sample Preparation 
In order to test to what degree the cellular and temperature conditions of a PFC 
influence its acquisition efficiency, several different PFPE cell samples were prepared 
from mouse-derived cells. All animal studies were approved by the local animal ethics 
committee. For in-vitro samples (i.e. the “in-vitro cellular condition”), bone-marrow-
derived macrophages (BMM) were isolated from 8-week-old female BALB/c mouse 
femurs and tibiae and incubated with 10 mg/ml PFPE for 18 h for in-vitro labeling. After 
washing three times in PBS, the cells were separated in two samples of 2.3×106 and 
3×106 cells each, and were collected in 2 ml tubes. For ex-vivo samples (i.e. the “ex-
vivo cellular condition”), five 10-week-old female BALB/c mice were intravenously 
injected with 4×106 PFPE-labeled BMM 3 days prior to euthanasia, after which their 
livers were collected and stored for 2 years at 4°C to investigate the stability of the 19F 
relaxation times over time. To test the effect of formaldehyde fixation on the PFPE 
relaxation times (i.e. the “fixed ex-vivo cellular condition”), four 8-week-old male/female 
ApoE-knockout mice were intravenously injected two times with 250 µL of PFPE. The 
animals were euthanized 2 days later, after which their spleen was excised, crushed 
through a 40 µM cell strainer and re-suspended in Dulbecco's Modified Eagle Medium 
(DMEM) containing 3% fetal calf serum (FCS). After centrifugation at 550 g, the cell 
pellets were re-suspended in 1% paraformaldehyde (PFA) in phosphate buffered saline 
(PBS) and incubated for 10 minutes at room temperature. After washing in PBS the 
cells were re-suspended to 10 million per mL in PBS.  
 Measurement of PFC 19F Relaxation Times 
All MR experiments were performed on a 3 T clinical scanner (Magnetom Prisma, 
Siemens, Erlangen, Germany) with a maximum gradient strength of 80 mT/m. A 35-
mm-diameter transmit/receive birdcage radiofrequency 19F/1H (RF) coil (Rapid 
Biomedical, Rimpar, Germany) was used. MR measurements were performed at either 
room temperature (24°C) or at body temperature (37°C). In order to monitor the 
temperature of the samples, a thermistor probe (SA Instruments, Stony Brook, NY) was 
used. Tubing with circulating warm water ensured constant temperature (37 ± 1°C). For 
all PFC agar phantoms, the relaxation times T1 and T2 and the T2/T1 ratio were 
determined.  
The relaxation times of the PFPE agar phantoms and the above-mentioned samples (in 
vitro, ex vivo, and fixed ex-vivo cellular conditions) were measured with unlocalized 
adiabatic spectroscopy. The T1 relaxation times were determined using an inversion 
recovery (IR) spin echo (SE) pulse sequence with a variable inversion time (10 values 
of TI=11 to 4000 ms) and a TR of 5 s. Integrals of peaks fitted with a three-parameter 
inversion recovery were used to ascertain the T1 value. The T2 relaxation times were 
measured by means of a SE pulse sequence with a variable echo time (7 values of 
TE=9.3 to 1000 ms) and TR=5 s. Integrals of peaks fitted with a two-parameter 
exponential decay were used for T2 determination. Adiabatic RF pulses were used in 
both pulse sequences. More specifically, a B1-Insensitive Rotation RF pulse (BIR-4) (21) 
was used as 90° RF excitation pulse, a hyperbolic secant RF pulse (HS1) (22) was 
used as RF inversion pulse, and a hyperbolic tangent (tanh) (23,24) as RF refocusing 
pulse.  
The T1 relaxation time of the PFCE agar phantom was evaluated with the same 
adiabatic IR-SE pulse sequence, with TI=11 to 8000 ms and TR=10 s. The T2 relaxation 
time was measured with the adiabatic SE pulse sequence with TE=19 to 2560 ms and a 
TR=10 s.  
The spectral characteristics of PFOB were obtained by means of unlocalized 
spectroscopy using a large receiver bandwidth (20’000 Hz), TR=5 s and a sinc RF 
excitation pulse with duration of 100 µs in order to excite all the resonance frequencies. 
 The T1 value of the different resonances of the PFOB agar phantom were evaluated 
using the adiabatic IR-SE pulse sequence with TI=11 to 8000 ms and TR=10 s. The T2 
values were measured twice: once with the above-mentioned adiabatic SE pulse 
sequences in order to measure the J-coupled relaxation times, and once with the same 
pulse sequence where all RF pulses have been replaced with Gaussian RF pulses 
(bandwidth=375 Hz at duration=5120 µs) to measure the non-J-coupled relaxation 
times. Due to the relatively small size of the phantoms compared to routine clinical 
shimming volumes, manual shimming was performed before each experiment in order 
to minimize the fluorine line width.  
Numerical Simulations  
In order to optimize the TSE pulse sequence, Bloch equation simulations (25) were 
performed in Matlab (The MathWorks, Inc, Natick, MA, USA). The signal per unit time, 
i.e. the signal normalized by            (26), was mapped as a function of TR, 
ETL, and BW for a PFC-specific set of T1 and T2 values as determined in the above-
described experiments. These maps were used to determine the combination of TR, 
ETL, and BW that leads to maximum signal strength per unit time. These simulations 
were performed both with and without a longitudinal magnetization restoration (LMR) 
RF pulse of -90° after the echo train (27).  
Acquisition Efficiency 
To define the link between relaxation times alteration and different temperature and 
cellular conditions, the acquisition efficiency η for that condition was then defined as: 
                                              
       
                 
                  
                                                                                                          
 
where S stands for the signal, while ref indicates the signal calculated at parameters 
obtained for the 24°C phantom (considered to be the reference) and cond indicates the 
signal calculated at parameters obtained for different relaxation times of the 
 temperature and cellular condition. The acquisition efficiency is expected to always be 
≤1, since the choice of sub-optimal parameters will inevitably lead to a lower signal. 
The simulated acquisition efficiency was experimentally verified by imaging the ex-vivo 
cellular condition with both the phantom reference parameters and its optimal 
parameters, and taking the ratio of the signal intensities normalized by 
          . This was repeated at 24°C and 37°C, and with and without the LMR 
pulse.  
Detection Limit Analysis 
The detection limit was separately determined for both the TSE and bSSFP pulse 
sequences. For the TSE pulse sequence, the PFC-specific optimal TR, ETL, and BW 
were determined as described above. Common parameters for all TSE imaging 
included: TE=13 ms, field of view (FOV)=64×64 mm2, matrix size=128×128, 128 signal 
averages, three slices with thickness 3 mm, 1 mm inter-slice distance, and BW=130 
Hz/pixel.  
Simultaneously, for the bSSFP pulse sequence, the optimal flip angle α that was used 
when determining the detection limit is given by (28):   
        
       
       
                                                                   
For all the PFC phantoms, bSSFP images were acquired with the following sequence 
parameters: TE=5.41 ms, TR=10.82 ms, FOV=64×64 mm2, matrix size=128×128, 128 
signal averages, three slices with thickness 3 mm, 1 mm inter-slice distance, and 
BW=130 Hz/pixel.  
The images obtained with both these optimized pulse sequences were analyzed in 
Matlab in order to determine the SNR of the detected tubes. Since a single-channel 
birdcage coil was used, the SNR of a region of interest (ROI) was calculated as the ratio 
between the average signal in the ROI and the standard deviation in a background ROI 
of at least 20 by 20 pixels outside the object of interest. For the PFOB phantom, the use 
of the lowest possible BW combined with the relative large chemical shifts between the 
 resonances (2-5 kHz) caused all chemical shift ghosts to appear well outside the 
phantom itself. This allowed any signal cancellation due to overlapping images from 
different resonances with different phases to be avoided. 
A linear fit of the 19F concentration versus the SNR was performed, and the minimum 
detectable concentration (i.e. the detection limit) was considered to be at SNR=4 (29). 
In order to normalize the values obtained with the two pulse sequences, the detection 
limit was normalized to an acquisition time of 600 s, a voxel volume of 1 mm3, and a 
pixel bandwidth of 300 Hz/px, yielding: 
 
                
     
      
     
   
      
     
   
      
       
 
                        
 
Where V is the volume, t is the duration of the pulse sequence, BW is the pixel 
bandwidth, C is the 19F molar concentration, norm denotes the values used for 
normalization, and act represents the actual values. 
Statistics 
For every PFC, the detection limit was calculated for each of the three imaged slices 
and for both the TSE and bSSFP pulse sequences. Data are therefore presented as 
mean ± standard deviation over the three imaged slices. A linear least squares fitting in 
which each data point carries equal weight has been used for the 19F concentration vs. 
SNR relationship, while an exponential least squares fitting was used to determine the 
T1 and T2 relaxation times. Since they are assumed to be normally distributed, the 
relaxation times are presented with their standard deviation. 
 
 RESULTS 
Characterization of PFCs 
The relaxation times of all samples have been successfully characterized to at least 
10% precision (Table 1). PFPE had a significantly lower T1 than the other compounds, 
while PFCE presented a high T2/T1 ratio. The PFOB spectrum at 3 T is characterized by 
five 19F resonance groups (30), since the CF2 (γ, δ-ε, ζ) multiplet was not completely 
resolved on the clinical system, despite manual shimming (Figure 1). The T1 relaxation 
times of all resonances of PFOB were similar, while there was a large difference 
between their T2 values due to J-coupling. Although RF pulses with a low bandwidth 
were used to selectively excite the individual peak of interest, in the case of the CF2 (γ, 
δ-ε, ζ) multiplet it was not possible to suppress the J-coupling effect (Table 2). 
Acquisition Efficiency  
Since the relaxation times depend on temperature and cellular conditions, the optimal 
TR and ETL for the TSE pulse sequence change accordingly. In particular, the T1 values 
of PFPE increased significantly with temperature in all conditions. The T1 value also 
increased in both the ex-vivo and in-vitro cellular conditions relative to the phantom (61-
86%, Figure 2a), while it increased slightly less in the fixed cells (21%). At both 
temperature conditions, the T2 value stayed approximately the same in both the in-vitro 
and ex-vivo conditions (Figure 2b), but decreased by 40% in the fixed ex-vivo condition.  
In general, for both the TSE pulse sequence with and without LMR, the lowest BW (i.e. 
130 Hz/px) allowed the signal maximization and thus the highest acquisition efficiency. 
In particular, for the TSE pulse sequence without LMR, a small decrease in pulse 
sequence acquisition efficiency η was observed at 24°C for the in-vitro, ex-vivo, and 
fixed ex-vivo cellular environments (6.5, 3.8 and 5.0%, respectively, Figure 3b), while a 
slightly larger decrease in η was observed at 37°C for all the cellular environments 
(10.0, 12.7, and 7.7%, respectively, Figure 3b). Similar but slightly smaller efficiency 
decreases were observed for the TSE pulse sequence with LMR on at both 24°C and 
37°C (Figure 3c).  
 The experimentally determined acquisition efficiencies in the ex-vivo samples showed 
good agreement with the simulated values based on the measured relaxation times 
(Figure 4). While there were differences up to 5% between the simulated and 
experimental acquisition efficiencies, the simulated results always fell within the 
standard deviation of the experimental results, and there was no consistent trend to the 
difference. 
Detection Limits 
For each PFC phantom, the relaxation times measured at both 24°C and at 37°C have 
been used to obtain the optimized parameters for the TSE pulse sequence with LMR off 
and on, and to obtain the optimal flip angle for the bSSFP pulse sequence (Table 3). 
The lowest available bandwidth choice consistently led to the highest signal per unit 
time for both pulse sequences. The pulse sequence optimization for the PFOB phantom 
was performed with the relaxation times of the CF3 (θ) peak, since this peak is 
characterized by the highest signal strength and the highest T2/T1 ratio. 
SNR measurements in the PFC phantoms at both 24°C and at 37°C (Figure 5) were 
used to obtain the optimized detection limit of both the TSE and bSSFP pulse 
sequences. It can be observed that when LMR was enabled, the detection limit for 
PFPE, PFCE, and PFOB for the TSE pulse sequence at both investigated temperatures 
improved (Table 4). 
DISCUSSION AND CONCLUSIONS  
In this study, the relaxation times of three perfluorocarbon emulsions that are commonly 
used in fluorine-19 MR imaging were determined at the clinical magnetic field strength 
of 3 T and were used to optimize the TSE and bSSFP pulse sequences. These 
optimized pulse sequences were then used to establish the detection limits of the PFCs 
and to investigate the loss of acquisition efficiency in three different conditions that 
represent the most common environments in which fluorine-19 MRI of PFCs is 
performed.  
 PFPE is characterized by the shortest T1 value, which allows for more rapid pulse 
sequences. It has been recently used in several preclinical inflammation studies (17,18) 
but it needs to be further investigated to allow clinical application, since, to our 
knowledge, its clearance rate from the body has not been studied yet. PFCE has the 
highest T2/T1 ratio and thus is ideal for the bSSFP pulse sequence. It has a single 
spectroscopic peak and it has been widely used for inflammation imaging (3,4) and cell 
tracking (31). However, it has been demonstrated that it remains in the liver and spleen 
for several months after administration (15). In contrast, PFOB remains in the liver and 
spleen a twenty-fold shorter time (15), it has been already used in humans as oxygen 
carrier (20) and the PFC fraction in the emulsion has been increased from 70% w/v (15) 
up to 90% w/v without compromising its stability (20,32,33). From a safety point of view, 
it therefore might be considered the best-suited candidate for inflammation imaging in 
humans. However, its complex spectrum causes chemical shift artifacts and signal loss 
due to homonuclear J-coupling. As reported in previous studies, this technical hurdle 
can be overcome by the use of a bSSFP ultrashort echo-time (UTE) pulse sequence 
(34), the use of a multi-chemical-shift-selective (MCSS) TSE pulse sequence (35), or 
the use of a SE sequence with a specific bandwidth of the refocusing pulse (36).  
The order of magnitude of the loss of acquisition efficiency η due to different cellular 
conditions was evaluated with PFPE and validated experimentally. In general, the T1 
value increased with temperature and in all cellular conditions, while the T2 value 
remained mostly the same as in the phantom, except for the fixed ex-vivo samples, 
where T2 was shorter due to the presence of formaldehyde (37). Fortunately the 
acquisition efficiency loss was moderate, and indicated that using the TSE pulse 
sequence with parameters optimized for a room-temperature agar-gel phantom would 
result in a usually acceptable signal loss in the body of less than 13% with LMR off and 
less than 9.5% with LMR on.  
The relaxation times and the optimized parameters determined in this study were also 
used to ascertain the detection limit of the different PFCs for the TSE and the bSSFP 
pulse sequences at both 24°C and at 37°C. For all the investigated PFCs, the use of 
longitudinal magnetization restoration (LMR) allows for higher SNR per unit time (26) 
 and therefore resulted in a slightly improved trend in the detection limit for the TSE 
pulse sequence. On the other hand, due to the LMR activation the optimal TR was 
significantly lower, limiting the time available for 2D multi-slice acquisition. For PFOB, 
only the CF3 (θ) resonance group was used and therefore only three out of seventeen 
19F nuclei were excited. As reported (34), this resulted in a significantly higher detection 
limit than PFPE and PFCE. In general, imaging performed at 37°C for both pulse 
sequences resulted in a higher detection limit, most likely due to higher T1 relaxation 
times and thus lower T2/T1 ratios.  
The relaxation times and detection limits found in this study were similar to those found 
by other groups for other field strengths and pulse sequences. Jacoby et al. (15) 
recently characterized a PFCE emulsion prepared as in this study at 9.4 T and found a 
similar T2/T1 ratio at 37°C. Mastropietro et al. (26) optimized the TSE pulse sequence 
for different phantoms of KPF6 and found a KPF6 detection limit of 0.5 mM in a water 
solution at 7 T. This value, when normalized as in the present study, resulted in a 
detection limit of 5 mM, comparable to those obtained in this study for PFCE at 3 T. 
Goette et al. (34) recently analyzed a PFOB phantom with a bSSFP UTE pulse 
sequence at 3 T (34). The T1 and T2 relaxation times for the CF3 (θ) were measured and 
agreed with those measured in the current study. The detection limits reported here are 
furthermore up to several orders of magnitude below the 19F tissue concentrations (~6 
M) that have been previously reported (7). Finally, the detection limit of PFCE with a 
gradient echo (GRE) pulse sequence was determined with a small surface coil at 9.4 T 
(38), which resulted in a detection limit of 0.5 mM when normalized as in this study, 
demonstrating the increase in signal sensitivity when using a small surface coil and 
higher magnetic field strengths. 
This study also has several limitations. The TSE pulse sequence parameters have been 
optimized on a theoretical basis, but the resulting acquisition efficiency was only 
validated in ex-vivo samples. It remains to be confirmed in the other sample types, 
although an experimental validation of the TSE parameter simulations was performed 
by Mastropietro et al. (26). The detection limit was furthermore ascertained in phantoms 
and remains to be investigated in vivo. However, the exact concentration in vivo will be 
 challenging to control, since it will depend on the animal's PFC absorption, clearance 
and biodistribution (i.e. species and time point after injection), while the detection limit 
might be overestimated due to animal motion. The RF coil used in this study (a 35-mm-
diameter birdcage) cannot be used in any human studies. However, this single-element 
birdcage has the advantage that it allows for direct quantification, which was required 
for the quantitative goals of this study. Simultaneously, the most suitable RF coil in an 
initial human application will strongly depend on the targeted body part, so a definitive 
human coil could not be chosen for this study. We would suggest using an array of 
small and sensitive surface coils in future initial human studies. Such arrayed surface 
coils (as for example used for the human carotids and hands) have similar, if not higher, 
sensitivities as the birdcage coil used here, but would make absolute quantification 
more challenging. Moreover, the used resolution was adapted to the specific RF coil 
and the phantom size (i.e. 6-mm-diameter syringes). However, since the detection limit 
scales linearly with the voxel size, it should be straightforward to extrapolate the results 
obtained in this study to any future human applications.  Finally, the specific absorption 
rate (SAR) has not been included as parameter in the simulation of the TSE pulse 
sequence, although all optimal parameter combinations were well within the SAR limits 
of the scanner.    
The detection limits reported in this study apply for 2D pulse sequences with a fully 
acquired k-space and a single-element volume coil at 3 T. For future applications, by 
applying compressed sensing (39) or by using a more sensitive surface coil or coil array 
and parallel imaging, it should be possible to further improve the detection limit of the 
acquisition system at 3 T. Moreover, since the voxel sizes commonly used in human 
applications (up to 2×2×8 mm3) are much larger than the size used here (normalized to 
1×1×1 mm3), it is reasonable to expect that a higher SNR could be obtained at similar 
concentrations, which may lead to an improved detection limit.  
In conclusion, we have reported relaxation times of three PFCs and determined their 
optimized detection limits at 3 T, and demonstrated that the loss of acquisition efficiency 
for PFC due to parameter settings optimized for the incorrect temperature and cellular 
condition is moderate.  
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 TABLES 
Table 1. Relaxation times of the perfluorocarbons used in this study. Unlocalized 
spectroscopy was performed to characterize PFPE, PFCE, and PFOB at 24°C and 
37°C. Only the CF3 resonance of PFOB is included, since it is characterized by the 
highest absolute value and by the highest T2/T1 ratio. The PFOB T2 relaxation time was 
measured through selective excitation. The relaxation time values are reported with one 
standard deviation. 
 
 
Resonance T1 (ms) T2 (ms) T2/T1 (-) 
    24°C 
PFPE 423 ± 25 155 ± 12 0.36 
PFCE 919 ± 31 588 ± 28 0.64 
PFOB [CF3 (θ)] 1092 ± 38 283 ± 20 0.26 
    37°C 
PFPE 597 ± 40 164 ± 8 0.27 
PFCE 1171 ± 30 596 ± 22  0.50 
PFOB [CF3 (θ)] 1416 ± 7 286 ± 30 0.20 
 
 
 
 
 
 
  
Table 2. Relaxation times of the PFOB resonances at 24°C. The PFOB T2 relaxation 
times were measured in phantoms at 24°C with and without selective excitation. In case 
of non-selective excitation, all the CF2 resonances are characterized by short T2 values. 
The CF2 (γ, δ-ε, ζ) multiplet is the only one that is still J-coupled despite the selective 
excitation. The relaxation time values are reported in order of decreasing resonance 
frequency and with one standard deviation. 
Resonance T1 (ms)                                     T2 (ms) 
          
 
  
 
Selective Excitation Non-Selective Excitation 
CF2Br (α) 1142 ± 43 184 ± 8 213 ± 23 
CF3 (θ) 1092 ± 38 283 ± 20 291 ± 29 
CF2 (β) 1170 ± 30 176 ± 9 7.2 ± 0.4 
CF2 (γ,δ-ε,ζ) 1108 ± 12 10.1 ± 1.3 6.8 ± 0.5 
CF2 (η) 1180 ± 35 195 ± 14 8.0 ± 0.4 
 
 
 
 
 
 
 
 
  
Table 3. Optimized pulse sequence parameters for PFCs at 24°C and 37°C. By 
means of T1 and T2 relaxation times measured at 24°C and 37°C, the optimized 
repetition time and echo train length with longitudinal magnetization restoration (LMR; a 
-90° “flip-back” pulse) off and on were determined for the PFCs in the TSE pulse 
sequence, as was the optimal bSSFP flip angle. For both pulse sequences, the pixel 
bandwidth was minimized to 130 Hz/px. In almost all the cases, the optimization with 
the LMR pulse on leads to a slightly faster pulse sequence. For comparison of these 
parameters, the resulting acquisition time for a single-slice image with 1 average and a 
128x128 matrix has been reported for the TSE pulse sequence. Similarly, for the 
bSSFP pulse sequence, the acquisition time for a single-slice image with 1 average, 
128x128 matrix and TR=10.82 ms has been reported.     
Resonance 
TSE LMR 
Off 
TSE LMR 
On 
TSE Acquisition 
Time (s) 
bSSFP 
Flip Angle 
(°) 
bSSFP 
Acquisition 
Time (s) 
 
                
     24°C 
 
TR 
(ms) ETL 
TR 
(ms) ETL LMR Off LMR On   
 
PFPE 825 12 485 7 8.8 8.8 62° 1.4 
PFCE 2075 40 795 16 6.6 6.3 77° 1.4 
PFOB [CF3 (θ)] 1925 22 915 11 11.2 10.6 54° 1.4 
  
37°C 
TR 
(ms) ETL 
TR 
(ms) ETL LMR Off LMR On   
 
PFPE 1075 13 585 7 10.6 10.7 55° 1.4 
PFCE 2465 42 945 17 7.5 7.1 71° 1.4 
PFOB [CF3 (θ)] 2365 23 1095 11 13.2 12.7 48° 1.4 
 
 
  
Table 4: PFCs Detection Limits at 3 T. The detection limit for different PFCs for 
optimized TSE and bSSFP pulse sequences at room temperature (24°C) and at body 
temperature (37°C) were determined. Despite the pulse sequence parameters being 
optimized for the relaxation times at 37°C, the detection limit was consistently higher 
when the temperature increased. The detection limit was normalized to an acquisition 
time of 600 s, a voxel volume of 1 mm3 and a pixel bandwidth of 300 Hz/px. The actual 
acquisition times for both TSE and bSSFP pulse sequences are reported. Note that the 
detection limits are expressed as fluorine atom concentrations (since these relate 
directly to the generated signal), and not as PFC molecule concentrations, which would 
result in lower values. 
Resonance 
19F pulse 
sequence 
 
Detection Limit (mM 19F)  Acquisition Time (s) 
      
 
  24°C 37°C 24°C 37°C 
 TSE LMR off 40.8 ± 5.9 51.5 ± 12.4 1126.4 1361.1 PFPE 
 TSE LMR on 36.6 ± 13.3 47.0 ± 14.1 1135.2 1369.2 
 
 bSSFP 23.5 ± 3.0 31.2 ± 4.8 177.3 177.3 
 
 TSE LMR off 35.7 ± 6.2 42.0 ± 9.1 892.5 941.1 PFCE 
 TSE LMR on 27.3 ± 6.1 35.1 ± 7.2 814.1 910.7 
 
 bSSFP 11.8 ± 3.0 21.8 ± 5.5 177.3 177.3 
 
 TSE LMR off 313.3 ± 33.0 379.9 ± 51.8 1429.9 1688.3 PFOB [CF3 (θ)] 
 TSE LMR on 287.4 ± 45.8 365.9 ± 5.5 1362.9 1638.4 
 
 bSSFP 92.2 ± 16.1 137.8 ± 7.9 177.3 177.3 
  
 
 FIGURE LEGEND 
 
Figure 1: The molecular structure and MR spectrum of perfluoro octylbromide at 
3 T. Two separate resonances can be observed (CF2Br (α) and CF3 (θ)) in addition to 
the J-coupled CF2 spectral group with five distinct spectral components. The horizontal 
axis was zeroed on the peak with the lowest resonance frequency. 
   
Figure 2: The effect of different cellular and temperature conditions on relaxation 
times. a-b) The T1 and T2 relaxation times of PFPE at different conditions. The 
relaxation times for the PFPE phantom were measured at 24°C. The T1 relaxation time 
consistently increased in the cellular environments, and more so at the higher 
temperature. The T2 relaxation time remained similar in all the conditions except the 
formaldehyde-fixed samples. Within the same cellular condition, the T2 relaxation time 
increased as the temperature increased. Bars indicate the best fit value while the error 
bars indicate one standard deviation. c-d) Representative T1 and T2 fit curves for the 
PFPE phantom at room temperature. A high R2 value (>0.99) for both relaxation curves 
confirmed the high fit quality.  
  
Figure 3:  Pulse sequence optimization and acquisition efficiency. a) An example 
of the results of the Bloch equation simulations of the TSE optimization for a fixed 
bandwidth of 130 Hz/pixel, with the normalized signal as a function of ETL and TR, in 
this case for the ex-vivo PFPE sample at 37°C with LMR on. The white cross indicates 
the maximum normalized signal for this condition, while the black dot indicates the 
normalized signal at the TR and ETL obtained from the simulation for the reference 
phantom at 24°C. The ratio of the signals at these two parameter settings defines the 
acquisition efficiency ɳ. b) Comparison of the relative acquisition efficiency η in the TSE 
pulse sequence with LMR off and c) LMR on for PFPE. With LMR off, the loss of η was 
small at room temperature (<6.5%), while it was moderate at body temperature (<13%). 
With LMR on, the loss of η was small at room temperature (<5.5%) and at body 
temperature (<10%).  
  
Figure 4: Experimental validation of the acquisition efficiency. a) The TSE pulse 
acquisition efficiency for the ex-vivo samples (i.e. the “ex-vivo cellular condition”) as 
compared to the reference at both 24°C and 37°C with the LMR pulse off and b) with 
the LMR pulse on. The results demonstrated a good agreement between the simulation 
and experiments. 
  
Figure 5: Illustration of the determination of the detection limit. a) An example of 
the drawn ROIs in a 19F image of the PFPE phantom containing syringes with different 
19F concentrations. The locations of the syringes were established in 1H images at the 
same location (not shown). b) An example of the linear curve fit of the calculated SNR 
versus 19F concentration with matching color coding. c) The zoomed-in region shows 
the minimum detectable concentration (black circle), which was considered to be at 
SNR=4 (horizontal green line).  
 
